Retrotope Starts IND Enabling Studies for its Second Deuterated Polyunsaturated Fatty Acid (D-PUFA) Drug Candidate, Targeting the Treatment of AMD and Related Retinal Pathologies.
LOS ALTOS, CA / ACCESSWIRE / July 21, 2020 / Retrotope announced today that it…
Telescope Innovations Reports Significant Milestones and Financial Results of Fiscal Year 2025
Sylogist Updates Investor Day Timing to April 9, 2026
Theralase(R) Closes $1.3 M Non-Brokered Private Placement
INEO Tech Corp. Closes $2.345 Million Non-Brokered Private Placement
Visionstate Announces Closing of Previously Announced Private Placement